QNCX supply chain intelligence for Quince Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CANTOR-FITZGERALD-CO | CANTOR-FITZGERALD-CO | 90% | On December 18, 2024, we entered into a Controlled Equity Offering Sales Agreement, with Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC, or the Agents, relating to the sale of shares of our c… |
| EUROPEAN-INVESTMENT-BANK | EUROPEAN-INVESTMENT-BANK | 90% | As a result of the Company’s payment of such amount, the Company’s and the Borrower’s obligations under the finance documents were deemed satisfied. |
| H-C-WAINWRIGHT-CO-LLC | H-C-WAINWRIGHT-CO-LLC | 90% | On December 18, 2024, we entered into a Controlled Equity Offering Sales Agreement, with Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC, or the Agents, relating to the sale of shares of our c… |
| PRF | PRF | 80% | Under the Termination Agreement, we agreed to reimburse PRF for certain fees and costs incurred in connection with the prosecution of the licensed patents prior to termination |
| ORANY | ORANY | 72% | nications containing warning or other safety information about the product; • fines, warning letters or holds on post-approval clinical trials; • refusal of the FDA to approve pending NDAs or supplem… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from QNCX graph: nications containing warning or other safety information about the product; • fines, warning letters or holds on pos… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ORANY | ORANY | 72% | nications containing warning or other safety information about the product; • fines, warning letters or holds on post-approval clinical trials; • refusal of the FDA to approve pending NDAs or supplem… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from QNCX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from QNCX graph: Reciprocal relationship from ORAN… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| QNCX-DEBT | Debt stack $293,000 | 90% | Market cache reports total debt of $293,000. |
| QNCX-DEBT-11996 | Warrants outstanding: 27941 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| QNCX-DEBT-11997 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2019-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| QNCX-OWNER-NANTAHALA-CAPITAL-MANAGEMENT-LLC | Nantahala Capital Management, LLC | 95% | 13F/ownership overlay lists Nantahala Capital Management, LLC; shares held 2,672,429; ownership 2.53%; value $435,605; as of 2025-12-31. |
| QNCX-OWNER-IEQ-CAPITAL-LLC | IEQ Capital, LLC | 95% | 13F/ownership overlay lists IEQ Capital, LLC; shares held 979,275; ownership 0.93%; value $159,621; as of 2025-12-31. |
| QNCX-OWNER-VANGUARD-GROUP-INC | Vanguard Group Inc | 95% | 13F/ownership overlay lists Vanguard Group Inc; shares held 2,084,015; ownership 1.97%; value $339,694; as of 2025-12-31. |
| QNCX-OWNER-ALMITAS-CAPITAL-LLC | Almitas Capital LLC | 95% | 13F/ownership overlay lists Almitas Capital LLC; shares held 930,134; ownership 0.88%; value $151,611; as of 2025-12-31. |
| QNCX-OWNER-MILLENNIUM-MANAGEMENT-LLC | Millennium Management Llc | 95% | 13F/ownership overlay lists Millennium Management Llc; shares held 1,190,352; ownership 1.13%; value $194,027; as of 2025-12-31. |
| QNCX-OWNER-WOODLINE-PARTNERS-LP | Woodline Partners LP | 95% | 13F/ownership overlay lists Woodline Partners LP; shares held 1,941,542; ownership 1.84%; value $316,471; as of 2025-12-31. |
| QNCX-OWNER-SUPERSTRING-CAPITAL-MANAGEMENT-LP | Superstring Capital Management LP | 95% | 13F/ownership overlay lists Superstring Capital Management LP ; shares held 858,711; ownership 0.81%; value $139,969; as of 2025-12-31. |
| QNCX-OWNER-STEMPOINT-CAPITAL-LP | Stempoint Capital LP | 95% | 13F/ownership overlay lists Stempoint Capital LP ; shares held 739,264; ownership 0.70%; value $120,500; as of 2025-12-31. |
| QNCX-OWNER-RENAISSANCE-TECHNOLOGIES-LLC | Renaissance Technologies, LLC | 95% | 13F/ownership overlay lists Renaissance Technologies, LLC; shares held 538,100; ownership 0.51%; value $87,710; as of 2025-12-31. |
| QNCX-OWNER-ADAGE-CAPITAL-PARTNERS-GP-L-L-C | Adage Capital Partners GP L.L.C. | 95% | 13F/ownership overlay lists Adage Capital Partners GP L.L.C.; shares held 2,250,000; ownership 2.13%; value $366,750; as of 2025-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| ORANY | ORANGE | 100.00 | 1 | ['customer', 'supplier'] |
| AMZE | Amaze Holdings, Inc. | 50.00 | 2 | |
| DWTX | Dogwood Therapeutics, Inc. | 50.00 | 2 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 50.00 | 2 | |
| AYTU | Aytu BioPharma, Inc. | 50.00 | 2 | |
| D | Dominion Energy, Inc. | 50.00 | 2 | |
| DARE | Daré Bioscience, Inc. | 50.00 | 2 | |
| CANF | Can-Fite BioPharma Ltd. | 50.00 | 2 | |
| DFTX | Definium Therapeutics, Inc. | 50.00 | 2 | |
| CHUC | Charlie's Holdings, Inc. | 50.00 | 2 | |
| CLNE | Clean Energy Fuels Corp. | 50.00 | 2 | |
| FENC | Fennec Pharmaceuticals Inc. | 50.00 | 2 | |
| EQR | Equity Residential | 50.00 | 2 | |
| CNOB | ConnectOne Bancorp, Inc. | 50.00 | 2 | |
| CYCN | Cyclerion Therapeutics, Inc. | 50.00 | 2 | |
| ESS | Essex Property Trust, Inc. | 50.00 | 2 | |
| ED | Consolidated Edison, Inc. | 50.00 | 2 | |
| SCNX | Scienture Holdings, Inc. | 50.00 | 2 | |
| CORT | Corcept Therapeutics Incorporated | 50.00 | 2 | |
| BLTE | Belite Bio, Inc | 50.00 | 2 |